Fault tolerant methods and architectures for embedded intelligence in medical leads

• US 8,855,765 B2
• Filed: 06/09/2011
• Issued: 10/07/2014
• Est. Priority Date: 06/09/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Spear, Thomas H., Germanson, Nancy M., Miller, Patrick D.
• Primary Examiner(s): Heller, Tammie K
• Application Number:
  US13/156,632
• Publication Number:
  US 20120316416A1
• Time in Patent Office: 1,216 Days
• Field of Search: 607/27, 607/28, 607/119, 600/508
• US Class Current: 607/28
• CPC Class Codes: A61B 5/318 Heart-related electrical modalities, e.g. electrocardiography [ECG]
• CPC Class Codes: A61B 5/7217 of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
• CPC Class Codes: A61N 1/0488 Details about the lead
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems

Abstract

The present disclosure pertains to methods, devices and systems for detection of a lead-related condition in a medical electrical lead. In accordance with the disclosure, a physiological waveform interpreter module embedded within the lead functions to sense the occurrence of a cardiac event and to generate a minimal impact signal. In an example implementation, the physiological waveform interpreter module is disposed proximate to the sensing site or vicinity of cardiac signals. The physiological waveform interpreter module transmits the minimal impact signal that may include one or more predetermined properties to a remotely located lead monitoring module upon sensing a cardiac event. The lead monitoring module receives and processes the minimal impact signal to determine whether a cardiac depolarization has occurred and simultaneously verify the integrity of the transmission medium.

Claims

1. An implantable medical system, comprising:

an electrode;

a medical electrical lead coupled to the electrode, including a physiological waveform interpreter (PWI) module having;

a data collection unit coupled to the electrode and configured to receive an electrical signal of a physiological signal sensed by the electrode; and

a reporting unit coupled to the data collection unit configured to generate a predetermined minimal impact signal that is indicative of the physiological signal in response to the sensed signal, the minimal impact signal having a different electrical property from the sensed signal; and

a medical device coupled to the lead including a lead monitoring circuit for receiving the minimal impact signal and processing the signal to determine whether a lead-related condition associated with the lead is present.

2. The implantable medical system of claim 1, wherein the PWI module comprises:

a sensing module for receiving the sensed electrical signals;

a processor coupled to the sensing module for processing the sensed electrical signals; and

a signal generator for generating the minimal impact signal.

3. The implantable medical system of claim 1, wherein the PWI module includes an encoder configured to encode the minimal impact signal.

4. The implantable medical system of claim 3, wherein the lead monitoring circuit comprises a decoder configured to decode the minimal impact signal.

5. The implantable medical system of claim 4, wherein the lead-related condition is determined to be present in response to a mismatch between the received decoded minimal impact signal and the generated minimal impact signal.

6. The implantable medical system of claim 1, wherein PWI module modulates a signature of the minimal impact signal in response to predetermined criteria.

7. The implantable medical system of claim 6, wherein the predetermined criteria includes the chamber in which the electrical signal is sensed.

8. The implantable medical system of claim 6, wherein the predetermined criteria includes the sensing of an intrinsic cardiac event.

9. The implantable medical system of claim 1, further comprising a signal evaluation unit configured to compare one or more properties of the received signal to a stored set of minimal impact signal properties to determine whether the lead-related condition is present.

10. The implantable medical system of claim 1, wherein the lead includes a conductor encapsulated by an insulative member and the lead-related condition comprises a defect of at least one of the conductor and the insulative member.

11. The implantable medical system of claim 1, wherein the minimal impact signal comprises predefined signal characteristics that are selected such that the minimal impact signal has a higher signal-to-noise ratio relative to a signal-to-noise ratio of the sensed electrical signal.

12. An implantable medical electrical lead, comprising:

a lead body;

an electrical conductor disposed within the lead;

a physiological waveform interpreter (PWI) module coupled to the electrical conductor, the PWI module including;

a data source for monitoring electrical signals indicative of a physiological event; and

a reporting unit configured to generate a minimal impact signal that is indicative of the physiological event in response to sensing a physiological event, the minimal impact signal having at least one electrical property that is different from the monitored electrical signals.

13. The implantable medical electrical lead of claim 12, wherein the monitored electrical signal is indicative of an intrinsic cardiac event.

14. The implantable medical electrical lead of claim 12, wherein the monitored electrical signal is indicative of a delivered pacing pulse having exceeded a capture threshold of cardiac tissue.

15. The implantable medical electrical lead of claim 12, further comprising means for telemetering a signal in response to sensing the physiological event.

16. The implantable medical electrical lead of claim 12, wherein the PWI module includes an encoder configured to encode the minimal impact signal.

17. The implantable medical electrical lead of claim 12, further comprising lead monitoring circuit for receiving the minimal impact signal and processing the signal to determine whether a lead-related condition is present.

18. The implantable medical electrical lead of claim 13, wherein the lead monitoring circuit is disposed on a proximal end of the lead body and the PWI module is disposed on a distal end of the lead body.